Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Gastroenterologia Y Hepatologia|June 21, 2020
Economic impact of health resource optimisation in the approach to patients with hepatitis CJuan Turnes, Federico García, Moisés Diago, et al.
Revista Espanola De Enfermedades Digestivas|November 23, 2020
Overall clinical and economic impact of non-alcoholic fatty liver diseaseAntoni Sicras-Mainar, Rocío Aller, Javier Crespo, et al.
Hepatology (Baltimore, Md.)|October 16, 2004
PTFE-covered stents improve TIPS patency in Budd-Chiari syndromeManuel Hernández-Guerra, Juan Turnes, Pablo Rubinstein, et al.
Gastroenterology|February 12, 2009
Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trialJuan G Abraldes, Agustin Albillos, Rafael Bañares, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|October 26, 2014
[Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients]María Buti, Blanca Gros, Itziar Oyagüez, et al.
Gastroenterologia Y Hepatologia|April 25, 2015
[Triple therapy in cirrhotic patients and those with advanced fibrosis: relevant aspects in clinical practice]Agustín Albillos, José Luis Calleja, Esther Molina, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosisJuan Turnes, Manuel Hernández-Guerra, Juan G Abraldes, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertensionManuel Hernández-Guerra, Juan C García-Pagán, Juan Turnes, et al.
United European Gastroenterology Journal|August 18, 2015
Application of the Barcelona Clinic Liver Cancer therapeutic strategy and impact on survivalManuel Hernández-Guerra, Alejandro Hernández-Camba, Juan Turnes, et al.
Pageof 8